Palo Alto, California, April 11, 2011 – OroScience plc (Palo Alto, CA), in conjunction with New Line Medical Inc. (Breaux Bridge, LA), will be exhibiting Periogenix at the New Orleans Dental Conference from April 14th to April 16th, 2011. Sponsored by the New Orleans Dental Association and the Louisiana Dental Association, this conference focuses on continuing education of dental practitioners on a regional, national and international level. The conference offers the attendees daily sessions presented by 34 nationally and internationally-renowned clinicians and clinical researchers.
Periogenix™ is a new oral wound dressing technology intended to protect injured periodontal tissue (gums) by forming a temporary physical barrier to avoid further irritation. Periogenix™ helps clinicians manage oral wounds by providing a barrier to assist in the process of acute and chronic wound healing. Clinical and animal studies demonstrate that Periogenix™ protects and safely promotes the healing of post-operative surgical wounds.
About OroScience
OroScience is a global professional oral care company dedicated to providing advanced therapies for the professional management of oral conditions such as oral wounds and mucositis. Our mission, helping nature heal, is woven into the fabric of OroScience’s organization and vision. In collaboration with leading clinicians, we develop, manufacture, and sell proprietary therapeutic dental and oral care products for oral wound healing, tissue regeneration, and oral disease management.
About New Line Medical, Inc.
New Line Medical, Inc. is an established dental and medical products distribution company headquartered in Louisiana with distribution along states on the Gulf Coast. New Line Medical is recognized as a preferred partner to dentists by the Louisiana and Mississippi Dental Associations.
** END OF PRESS RELEASE **
OroScience plc is an independent, stock exchange listed manufacturer of professional oral care products. This news release may contain certain forward-looking statements, expectations, intentions, strategies and beliefs regarding the future. All statements contained herein are based upon information available to the management of OroScience plc as of the date hereof, and actual results may vary based upon future events, both within and without the control of the management, including risks and uncertainties that could cause actual results to differ materially.
Management does not take any responsibility to update the contents of this News Release in case new aspects arise or new conditions change the facts available.
OroScience plc
2275 E. Bayshore Rd, Suit 105
Palo Alto, CA 94303
www.oroscience.com
ISIN IE00B40WCY19, WKN A0X9H7,
Exchange: Vienna stock exchange, Frankfurt Stock Exchange
Media Contact:
Phil Houle (650)-856-9600
Chief Executive Officer
phoule@oroscience.com
